- HOME
- Business
The SBI Group has achieved dramatic growth centered around its three major businesses: the Financial Services Business, which includes online securities, banking, and insurance; the Asset Management Business, which primarily invests in venture companies; and the Biotechnology, Healthcare and Medical Informatics Business, which develops and markets pharmaceuticals, health foods, and cosmetics, as well as research and development of new drugs.
Currently, the SBI Group has shifted to the five businesses: "Financial Services Business," "Investment Business," "Asset Management Business," "Crypto-asset Business," and " Next Gen Business". To achieve our goal of "going beyond finance with finance as its core," we will continue to focus on providing products and services using advanced technology and creating new business opportunities.
- Mar 26
- Notice Regarding Conversion of Zero Coupon Convertible Bonds due 2025
- Mar 22
- Notice Regarding Investment in Sturgeon Emerging Opportunities II, a Startup Investment Fund Targeting Central Asian Region with Focus on Uzbekistan
- Mar 21
- Notice Regarding Investment in Solaris SE, which Provides Banking Functions to Partner Companies in Europe Through Embedded Finance
- Feb 29
- Notice of Exercise of Call Option on the Zero Coupon Convertible Bonds due 2025
- Feb 7
- Notice Regarding Revision to Dividend Forecast and Implementation of the 25th Anniversary Commemorative Dividend
- Jan 31
- SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY
- list